HOLX
Hologic Inc
NASDAQ: HOLX · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$76.01
+0.00% today
Updated 2026-04-07
Market cap
$16.97B
P/E ratio
31.54
P/S ratio
4.11x
EPS (TTM)
$2.41
Dividend yield
—
52W range
$52 – $76
Volume
5.0M
WallStSmart proprietary scores
51
out of 100
Grade: C
Hold
Investment rating
2.7
Growth
F8.0
Quality
A6.5
Profitability
B4.3
Valuation
C5/9
Piotroski F-Score
Moderate
2.4
Altman Z-Score
Grey zone
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$76.67
+0.87%
12-Month target
$72.23
-4.97%
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy0 Buy15 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Free cash flow $215.20M — positive
+ Debt/equity 0.48x — low leverage
Risks
No major risks identified
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $4.86B | $4.03B | $4.03B | $4.10B | $4.13B |
| Net income | $1.30B | $456.00M | $789.50M | $565.70M | $179.10M |
| EPS | — | — | — | — | $2.41 |
| Free cash flow | $2.00B | $901.00M | $1.15B | $920.10M | $215.20M |
| Profit margin | 26.77% | 11.31% | 19.59% | 13.80% | 13.20% |
Peer comparison
Smart narrative
Hologic Inc trades at $76.01. representing a P/E of 31.54x trailing earnings. Our Smart Value Score of 51/100 indicates the stock is fair. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of 2.37, it sits in the grey zone. TTM revenue stands at $4.13B. with profit margins at 13.20%.
Frequently asked questions
What is Hologic Inc's stock price?
Hologic Inc (HOLX) trades at $76.01, on a P/E of 31.5x and a P/S of 4.1x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Hologic Inc overvalued?
Hologic Inc carries a Smart Value Score of 51/100 (Grade C), which we rate Hold. That score blends growth, quality, and valuation into one read.
What is the price target of Hologic Inc (HOLX)?
The 12-month analyst consensus target is $76.67, about 0.9% above the current $76.01. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is Hologic Inc's revenue?
Hologic Inc's trailing twelve-month revenue is $4.13B. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Hologic Inc's Altman Z-Score is 2.37, which places it in the grey zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL INSTRUMENTS & SUPPLIES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio4.11x
ROE10.37%
Beta0.70
50D MA$75.30
200D MA$71.34
Shares out0.22B
Float0.22B
Short ratio—
Avg volume5.0M
Performance
1 week+0.00%
1 month+0.00%
3 months+1.14%
YTD+2.04%
1 year—
3 years—
5 years—